Author:
Laura Balanescu,Radu Balanescu,Patricia Cimpeanu,Andreea Moga
Abstract
Background: Neuroblastoma (NB) is the most common pediatric extracranial solid tumor and the most common cancer encountered in children younger than 12 months of age. Localized tumors have a good prognosis, but some cases undergo treatment failure and recurrence. The aim of the study was to analyze the link between the neuroblastoma risk factors and the prognosis for patients diagnosed with NB. Method: All patients admitted to the department of Pediatric Surgery, “Grigore Alexandrescu” Clinical Emergency Hospital for Children, between 1 January 2010 and 1 July 2022 were included in this analysis when diagnosed with neuroblastoma. Results: Thirty-one patients with NB were admitted to the surgical department, 20 boys and 11 girls. We observed an association between large tumors and positive imaging-defined risk factor (IDRF) status; The Fisher test showed an association between the tumor’s diameter when bigger than 8 cm and a positive IDRF status, with p < 0.001. We supposed that positive IDRF status at diagnosis may be linked to other prognostic factors. We discovered that an NSE value over 300 was associated with IDRF status (p < 0.001, phi = 0.692) and death. Conclusions: This study confirms the impact of IDRF status at diagnosis as it can be clearly correlated with other risk factors, such as a high level of NSE, MYCN amplification status, large tumor size, incomplete tumor resection, and an unfavorable outcome.
Subject
Pediatrics, Perinatology and Child Health
Reference57 articles.
1. Updates in diagnosis, management, and treatment of neuroblastoma;Swift;Radiographics,2018
2. Image-defined Risk Factors Correlate with Surgical Radicality and Local Recurrence in Patients with Neuroblastoma;Pohl;Klin. Padiatr.,2016
3. Neuroblastoma: A Disease Requiring a Multitude of Imaging Studies Continuing Education;Kushner;J. Nucl. Med.,2004
4. A review of neuroblastoma image-defined risk factors on magnetic resonance imaging;Chen;Pediatr. Radiol.,2018
5. Braoudaki, M., Hatziagapiou, K., Zaravinos, A., and Lambrou, G.I. MYCN in Neuroblastoma: “Old Wine into New Wineskins”. Diseases, 2021. 9.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献